3 min listen
Targeting Pain
ratings:
Length:
12 minutes
Released:
Dec 5, 2022
Format:
Podcast episode
Description
Quána Madison is one of the millions of Americans living with chronic pain. Dressing herself or even showering can be excruciating. Dr. Paul Negulescu and the research team at Vertex are thinking differently about pain – they’re investigating potential non-opioid based treatment options that aim to target pain where it starts. Produced by Bloomberg Media Studios and Vertex Pharmaceuticals. Featured guests:Quána Madison is an artist, mindfulness teacher, healing arts workshop facilitator, self-leadership coach, model and artist-philanthropist. She lives with chronic pain.Norm Buckley is the Scientific Director of the Michael G. DeGroote Institute for Pain Research and Care at McMaster University. David Altshuler is the Executive Vice President, Global Research and Chief Scientific Officer at Vertex Pharmaceuticals.Paul Negulescu is a renowned cystic fibrosis researcher and now the Senior Vice President leading the team researching pain at Vertex Pharmaceuticals.Read more about Vertex's approach to targeting pain.
Released:
Dec 5, 2022
Format:
Podcast episode
Titles in the series (7)
Introducing, Targeting the Toughest Diseases: Targeting the Toughest Diseases looks at some of humanity’s most challenging diseases and how Vertex, a Boston-based biotech company, is using innovative tools, methods, and a unique philosophy to search for treatments and cures. Produced by Bloomberg Media Studios and Vertex Pharmaceuticals. The first episode drops October 10th. Subscribe today. by Targeting the Toughest Diseases